Similar Low Rates of HCV Recurrence in HCV/HIV- and HCV-Infected Participants who Achieved SVR After DAA Treatment: Interim Results From the ACTG A5320 Viral Hepatitis C Infection Long-term Cohort Study (V-HICS).

TitleSimilar Low Rates of HCV Recurrence in HCV/HIV- and HCV-Infected Participants who Achieved SVR After DAA Treatment: Interim Results From the ACTG A5320 Viral Hepatitis C Infection Long-term Cohort Study (V-HICS).
Publication TypeJournal Article
Year of Publication2018
AuthorsWyles DL, Kang M, Matining RM, Murphy RL, Peters MG
Corporate AuthorsVHICS Study Team
JournalOpen Forum Infect Dis
Volume5
Issue6
Paginationofy103
Date Published2018 Jun
ISSN2328-8957
Abstract

Hepatitis C virus (HCV) recurrence rates were similar between those with HCV/HIV co-infection (0.35/100 person-years) and HCV infection (0.42/100 person-years). Low rates of recurrence likely represent enrollment of an HIV population at low risk for recurrence. Care should be taken not to label all HCV/HIV co-infected patients as being at high risk for HCV recurrence.

DOI10.1093/ofid/ofy103
Alternate JournalOpen Forum Infect Dis
PubMed ID29977962
PubMed Central IDPMC6016417
Grant ListUM1 AI068634 / AI / NIAID NIH HHS / United States
UM1 AI068636 / AI / NIAID NIH HHS / United States
UM1 AI069471 / AI / NIAID NIH HHS / United States
UM1 AI106701 / AI / NIAID NIH HHS / United States